Authors : Fatima Jabeen

Volume/Issue : Volume 10 - 2025, Issue 7 - July

---

Google Scholar : https://tinyurl.com/chpe5w8p

Scribd : https://tinyurl.com/ycu23jd3

DOI : https://doi.org/10.38124/ijisrt/25jul243

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

---

Abstract : The research is based upon analysis of Dexcom Inc., that is considered as performing a leading role in continuous glucose monitoring (CGM) systems. It analyses the plan of action, its challenges & the possible effects in the system, specifically in continuous emergence of health care systems. By using the indirect information and doing qualitative analysis, the study has identified some fundamental problems in the system. The issues are related to management I.e., innovation management, data privacy & world health care arrangements. The article delivers the well thought recommendations to improve Dexcom's Strategic durability and global influence. The insights that are provided, they have the purpose to support identical health care technology startups that are experiencing difficult market circumstances.

Keywords : Dexcom Inc., Continuous Glucose Monitoring,, Health Care Innovation, Data Security, Plan of Action.

References :

1. Christensen, C. M., Grossman, J. H., & Hwang, J. (2016). The Innovator’s Prescription. McGraw-Hill.
2. Porter, M. E., & Teisberg, E. O. (2006). Redefining Health Care. Harvard Business School Press.
3. HHS (2021). Cybersecurity Best Practices in Healthcare.
4. Dexcom Inc. (2023). Annual Financial Report.
5. EMA (2021). Regulatory Pathways for Medical Devices.
6. FDA (2022). Guidelines for CGM Systems.
7. WHO (2020). Digital Health Strategy 2020–2025.
8. Smith, A., & Patel, V. (2021). Journal of Health Informatics, 18(2), 45–59.
9. Lee, M., & Hernandez, J. (2020). Global Health Strategy Journal, 12(3), 123–137.